Most Recent
A law firm that brought class actions against Hyundai and Kia over alleged faulty anti-lock braking systems has been replaced ahead of a contest against Maurice Blackburn to run the cases.
Network Ten, which is resisting paying the legal bill for Lisa Wilkinson in defamation proceedings by accused rapist Bruce Lehrmann, has argued it is only on the hook for paying costs "reasonably incurred" by the presenter.
A leading plaintiff law firm will file a competing class action against KFC before the end of the year alleging the fast food giant denied workers rest breaks, after Gordon Legal filed a group proceeding late last month, a court has heard.
The CEO of Optus has denied it has to compensate small businesses who allegedly suffered losses during a nationwide outage that left over ten million customers without coverage or pay a penalty for 228 emergency calls to 000 that failed.
A union has partially won a bid to exclude thousands of current and former members from a class action against McDonald’s, after losing a challenge that sought to ban all Fair Work group proceedings.
A human rights group has lost its legal bid to compel the federal government to bring home Australians stuck in Syrian camps, with a a judge finding the Minister for Home Affairs has “no control” over their detention.
Ten has questioned whether presenter Lisa Wilkinson should have separate representation in defending a defamation case by accused rapist Bruce Lehrmann, as it responds to a dispute over a promise to cover her legal bill.
The Office of the Australian Information Commissioner has brought civil penalty proceedings accusing pathology services provider Australian Clinical Labs of failing to take steps to prevent a February 2022 data breach that affected millions of patients.
Tiwi Islanders have won an eleventh hour bid to halt all work on Santos' Barossa gas export pipeline for one week, with a judge finding construction could cause "irreparable damage" to underwater cultural heritage.
Novartis unit Sandoz AG has lost its bid to revoke Bayer’s patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giant’s patents were valid.